Bafna Pharmaceuticals Ltd

BAFNAPH

Company Profile

  • Business description

    Bafna Pharmaceuticals Ltd is an Indian pharmaceutical company mainly offering Contract Research and Manufacturing (CRAMS), Technology Transfers, Formulation, and Analytical Development services. It is engaged in the business of manufacturing finished pharmaceutical formulations, specializing in non-betalactam solid oral dosage forms, besides other emerging and potential products and forms in various therapeutic areas such as cardiology, lifestyle and potent drugs, and pain management. The company delivers generic pharmaceutical products for the UK, Australia, the EU, and emerging markets. In addition, it has launched its own brands in Sri Lanka, the Philippines, Tanzania, and Nigeria, offering products for some high-demand therapies like diabetes, cardiovascular, and oncology.

  • Contact

    Thambu Chetty Street
    New No. 68, Old No. 299, Bafna Towers
    ChennaiTN600001
    IND

    T: +91 4425267517

    http://www.bafnapharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    406

Stocks News & Analysis

stocks

Lower production and higher prices for ASX hydrocarbon play

Improving pricing offsets severe weather impact on sales volumes.
stocks

Alphabet returns on AI investments accelerating

AI propels business across aegments, cloud is grightest; Increasing our fair value.
stocks

We lift our fair value estimate for this ASX energy play

Strong oil and LNG prices are a major win, though we don’t think they will stay high in the long term.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,887.6017.100.19%
CAC 408,022.2349.90-0.62%
DAX 4024,007.0552.490.22%
Dow JONES (US)48,861.81280.12-0.57%
FTSE 10010,312.1499.030.97%
HKSE25,776.53335.31-1.28%
NASDAQ24,673.249.440.04%
Nikkei 22559,284.92632.54-1.06%
NZX 50 Index12,903.31133.011.04%
S&P 5007,135.952.85-0.04%
S&P/ASX 2008,665.8025.600.30%
SSE Composite Index4,112.164.650.11%

Market Movers